Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
4DMedical Ltd ( (AU:4DX) ) has provided an announcement.
4DMedical Limited has lodged a supplementary prospectus with the Australian Securities and Investments Commission, amending the terms of its New Options and Piggyback Options offers. The company has streamlined the application process for eligible participants, who will automatically be deemed to have applied for their allocation unless they choose to opt out. This move aims to simplify participation and potentially increase stakeholder engagement in anticipation of future FDA clearance for its CT:VQ technology.
More about 4DMedical Ltd
4DMedical Limited is a company specializing in respiratory imaging technology. It focuses on developing advanced imaging solutions to enhance lung health diagnostics and treatment, positioning itself prominently in the healthcare technology industry.
YTD Price Performance: -46.88%
Average Trading Volume: 996,128
Technical Sentiment Signal: Buy
Current Market Cap: A$114.9M
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.